Symbolbild · KI-generiert
BetterLife Pharma Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
BetterLife Pharma Inc. is an emerging biotechnology company primarily focused on developing and commercializing a compound, BETR-001, to treat neuro-psychiatric and neurological disorders. BETR-001 is a non-hallucinogenic and non-controlled LSD derivative in development and it is unique in that it is unregulated and therefore can be self-administered. BetterLife’s synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent for composition and method of use covers treatment of depression, cluster headaches, post-traumatic stress disorder and other neuro-psychiatric and neurological disorders. BetterLife also owns a drug candidate for the treatment of viral infections and is in the process of seeking strategic alternatives for further development.
Company description as published by the issuer via Canadian Securities Exchange.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| BetterLife Pharma Inc. | BETR | CSE | 33 Mio. USD |
| LSL Pharma Group Inc. | LSL | TSXV | 34 Mio. USD |
| MedMira Inc. | MIR | TSXV | 32 Mio. USD |
| Perimeter Medical Imaging AI Inc. | PINK | TSXV | 32 Mio. USD |
| NurExone Biologic Inc. | NRX | TSXV | 30 Mio. USD |
| BriaCell Therapeutics Corp. | BCT | TSX | 30 Mio. USD |
| Sernova Biotherapeutics Inc. | SVA | TSX | 30 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.